Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,942,561 papers from all fields of science
Search
Sign In
Create Free Account
lodamin
Known as:
mPEG-PLA-TNP-470
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Polyesters
Sesquiterpenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug
Takeru Yoshimura
,
Ofra Benny
,
L. Bazinet
,
R. D'Amato
PLoS ONE
2013
Corpus ID: 34001975
Chronic and recurrent uveitis account for approximately 10% of legal blindness in the western world. Autoimmune uveitis is driven…
Expand
2013
2013
Abstract 2140: Oral antiangiogenic therapy suppresses xenograft growth and is well tolerated in rats.
Ofra Benny
,
L. Bazinet
,
R. D'Amato
2013
Corpus ID: 70580739
Lodamin, the oral formulation of TNP-470, a methionine aminopeptidase 2 (MetAp2) inhibitor, was previously shown to significantly…
Expand
Highly Cited
2011
Highly Cited
2011
Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis
C. Becker
,
P. Beaudry
,
+6 authors
S. Ryeom
American Journal of Pathology
2011
Corpus ID: 3833162
2010
2010
Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases
Ofra Benny
,
K. Nakai
,
+7 authors
R. D'Amato
PLoS ONE
2010
Corpus ID: 1140404
Pathological neovascularization is a hallmark of late stage neovascular (wet) age-related macular degeneration (AMD) and the…
Expand
2010
2010
Angiogenesis and Tissue Engineering Research
D. Ingber
,
M. Puder
,
J. Bischoff
2010
Corpus ID: 68221571
Abstract : Centers on the development of new medical therapies and regenerative medicine approaches for the treatment of injured…
Expand
Highly Cited
2008
Highly Cited
2008
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Ofra Benny
,
O. Fainaru
,
+9 authors
J. Folkman
Nature Biotechnology
2008
Corpus ID: 7206588
Targeting angiogenesis, the formation of blood vessels, is an important modality for cancer therapy. TNP-470, a fumagillin analog…
Expand
2008
2008
Hitting the mother lode of tumor angiogenesis
D. James
,
S. Rabbany
,
S. Rafii
Nature Biotechnology
2008
Corpus ID: 205269294
Despite promising early results, cancer therapy aimed at selective destruction of tumor blood vessels faces several hurdles…
Expand
2008
2008
Lodamin (PEG-PLA-TNP-470), a novel formulation for oral administration of TNP-470 as a potent antiangiogenic and anti-cancer drug.
Ofra Benny
,
O. Fainaru
,
L. Bazinet
,
S. Koirala
,
G. Corfas
,
J. Folkman
2008
Corpus ID: 79597437
1118 Targeting angiogenesis, the formation of new blood vessels, is becoming an important strategy for cancer therapy. TNP-470…
Expand
2008
2008
Angiogenesis: A less bitter pill
P. Goymer
Nature Reviews. Cancer
2008
Corpus ID: 46098883
inhibitor TNP-470 is a potent suppressor of tumour growth and metastasis, but its use is limited because it requires lengthy…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE